Monday, January 31, 2011

J&J Generics Deal May Speed AIDS Drug Access in Africa, India

January 28, 2011, 2:03 PM ESTBy Alex Nussbaum
Jan. 28 (Bloomberg) -- Johnson & Johnson struck the first deal to license an experimental AIDS drug before regulatory approval, reigniting debate over how much companies should do to speed access to HIV treatments in poor countries.
J&J’s Tibotec Pharmaceuticals unit has agreed to let three generic drugmakers provide copies of TMC278 in sub-Saharan Africa, India and parts of Asia if it’s approved by regulators, the company said yesterday in a statement. If past AIDS drugs are a guide, that could make the pill available for a hundredth of the price that customers pay in the United States, said Mitchell Warren, executive director of the New York-based AIDS Vaccine Advocacy Coalition.

House of Numbers: Luc Montagnier, Nobel Prize Winner, Takes Homeopathy Seriously

Posted: January 30, 2011 11:49 AM -

Dr. Luc Montagnier, the French virologist who won the Nobel Prize in 2008 for discovering the AIDS virus, has surprised the scientific community with his strong support for homeopathic medicine. 
In a remarkable interview published in Science magazine of December 24, 2010, (1) Professor Luc Montagnier, has expressed support for the often maligned and misunderstood medical specialty of homeopathic medicine. Although homeopathy has persisted for 200+ years throughout the world and has been the leading alternative treatment method used by physicians in Europe, (2) most conventional physicians and scientists have expressed skepticism about its efficacy due to the extremely small doses of medicines used.

Sunday, January 30, 2011


Ten Lies About Aids - Trafford

by Etienne De Harven, M.D. with Jean-Claude Roussez

1 - AIDS is a new syndrome;
2 - The existence of HIV has been appropriately demonstrated;
3 - HIV is actually the cause of AIDS;
4 - Antiretroviral medications are helpful for AIDS sufferers;
5 - Seropositivity indicates an active process of HIV infection;
6 - AIDS is a contagious pathological process;
7 - HIV is responsible for numerous illnesses;
8 - It is better for people to know their serological HIV status;
9 - There is indeed an AIDS pandemic affecting the general population;
10 - All medical researchers agree, indisputably, that HIV is the cause of AIDS.

10 - All medical researchers agree, indisputably, that HIV is the cause of AIDS.

Ten Lies About Aids - Trafford

This&That: WONDERFUL INTERVIEW -Dr. Nancy Turner Banks

This&That: WONDERFUL INTERVIEW -Dr. Nancy Turner Banks

Wednesday, January 26, 2011

Gilead Sciences Receives "Refuse to File" Notification From U.S. FDA on New Drug Application for Single-Tablet Regimen of Truvada and TMC278 - The Body

Gilead Sciences Receives "Refuse to File" Notification From U.S. FDA on New Drug Application for Single-Tablet Regimen of Truvada and TMC278 - The Body

Has Anyone Seen The Trailer to the New Documentary expose of the Aids inc on youtube called "HOUSE OF NUMBERS"?

Director Brent Leung is a brave man. but what makes his explosive documentary, House of Numbers, so undeniably effective, is that he didn't set out to be. As he tells us in the film, he was born in 1980...part of the first AIDS generation, a group who came into their sexuality with the threat of HIV strapped to their genitals like a potentially lit bundle of dynamite. a few years ago, Leung came to learn there has always been a debate over the current HIV/AIDS scientific paradigm. having never known a world without AIDS, this intrigued him, and so his investigative journey began. he was not trying to show courage through radical activism or by asserting some aggressive agenda. he had some questions, and he went around the world asking top HIV/AIDS scientists for the answers.

Wednesday, January 19, 2011

Limbaugh's Latest AIDS Rant

Page 1 of 1

Limbaugh's Latest AIDS Rant

In his latest antigay rant,Rush Limbaugh suggeststhat the Democratic Party blames the AIDS epidemic on Ronald Reagan because they want people to believe he had the disease and spread it himself through gay sex.
On Monday’s Rush Limbaugh Show, the conservative talk radio host said: “These people blamed AIDS on Reagan. Sound familar? They blamed homelessness on Reagan -- you know why they blamed AIDS on Reagan? Because he didn't care. Because he never delivered a speech about it. And because of that, AIDS was spread. They actually wanted us to believe that Reagan had the disease, was sneaking into gay people's houses at night, and impregnating them with the disease and running out.”
In 2004, while complaining that Reagan had been unfairly attacked for failing to prevent the AIDS epidemic, he said that AIDS activists said it was “only a matter of time before it spreads to the heterosexual community… nd of course it -- it hasn't. It -- it didn't, and it hasn't, other than in Africa.”
He said in Africa, AIDS is spread by promiscuity.

Monday, January 3, 2011

Abbott's HIV drug patent plea rejected for lack of novelty

Business Standard
Tuesday, Jan 04, 2011

BS Reporter / New Delhi January 04, 2011, 1:23 IST
India has rejected an HIV drug patent application filed by US-based Abbott Laboratories, as it lacked “novelty” under domestic laws. The denial of patent will help domestic drug-makers to produce and market low-cost versions of this drug in the developing world.
The rejection of Abbott’s patent application over a combination of lopinavir and ritonavir, sold under the brand name Aluvia, ended the four-year long intellectual property battle between the company and four pre-grant opponents.

In its order on December 30, Mumbai patent office said the drug lacked novelty and did not have any innovative production steps to qualify for patent protection under domestic laws. The Indian Patent Act does not permit patenting of incremental innovations of known substances.

Hailing the verdict, civil society groups said it sets an important precedent to stop pharmaceutical companies from “gaming” the patent system.

AHF Will Supply $1 Million in Free AIDS Drugs to Florida Wait List Patients

AHF Will Supply $1 Million in Free AIDS Drugs to Florida Wait List Patients

AHF Pharmacy Will Supply $1 Million in Free AIDS Drugs to Patients on the Waiting List for Florida’s AIDS Drug Assistance Program—and to those 350 ADAP Patients the State Will Disenroll from its ADAP program. AHF Pharmacy will Supply at No Cost a Five-Day Supply of Lifesaving HIV Drugs for Patients until they Enroll In and Receive Refills from Private Drug Company Patient Assistance Programs
2,396 People—More than Half of the 4,543 Currently on ADAP Waiting Lists Nationwide—are in Florida, Which also Has the Third Highest HIV Population in the Nation
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--As the State of Florida grapples with a budget shortfall that has crippled its AIDS Drug Assistance Program (ADAP) and forced the state to potentially disenroll 350 Florida patients already on ADAP as well as place nearly 2,400 low-income Floridians on waiting lists to access lifesaving medications, AIDS Healthcare Foundation (AHF) has proposed an innovative plan to help state health officials and displaced HIV/AIDS patients bridge the transition to private patient assistance programs run by the major pharmaceutical companies. AHF, through its AHF Pharmacy, will supply up to $1 million in free AIDS drugs to those disenrolled and wait listed HIV/AIDS patients on medication therapy as those patients wait for their medications to be delivered from private patient assistance programs. This will avoid any interruption in lifesaving medication therapy while patients transition onto patient assistance programs.
“Through AHF’s offer to fill prescriptions for medications to bridge supply gaps for any displaced Florida ADAP patients, we hope to help ease the state’s AIDS drug crisis and get vulnerable Florida AIDS patients off waiting lists and back on to lifesaving antiretroviral treatment”
“Through AHF’s offer to fill prescriptions for medications to bridge supply gaps for any displaced Florida ADAP patients, we hope to help ease the state’s AIDS drug crisis and get vulnerable Florida AIDS patients off waiting lists and back on to lifesaving antiretroviral treatment,” said Michael Weinstein, President of AIDS Healthcare Foundation. “We have initially proposed offering five-day supplies of medications to patients, which should be ample time for private drug companies to confirm patient eligibility for their respective patient assistance programs, or time enough to spur greater efficiency among those drug companies whose enrollment protocols may be unnecessarily cumbersome.”

Sunday, January 2, 2011

60 Minutes Reports Glaxo Debacle

Since 1991, the pharmaceutical industry has paid at least $19.8 billion to settle hundreds of criminal and civil complaints related to the negligence and illegal marketing of drugs that kill or injure more than a million Americans every year.  The AMA reports that, if tracked like real diseases, adverse drug reactions (ADRs) would rank between the fourth and sixth leading cause of US mortality – far above the alleged risks of HIV infection. 
These facts are no accident.  As long as the drug and healthcare industries continue to profit from preventable errors, complications and ADRs, the fines will be viewed as little more than a corporate tax – paid for by the consumers and taxpayers who suffer at the hands of these corporations. 
This evening, CBS 60 Minutes covered the Glaxo corruption and the retaliation against the whistleblower who reported it.

More of the interview is posted at 60 Minutes.

Saturday, January 1, 2011

Gilead could change the game for HIV patients

Date: Friday, December 31, 2010, 3:00am PST

Biotech: Pill to watch-Gilead Sciences' Quad pill
 Foster City-based Gilead could change the game for HIV patients and its bottom line, adding a new drug and booster to its once-a-day pill.
The so-called Quad pill and its elements are undergoing three Phase III studies. A fourth 700-patient trial is enrolling.
About half of the HIV patients who start therapy in the United States already use Gilead’s three-in-one Atripla, which uses Bristol-Myers Squibb’s Sustiva. The Quad pill drops the Bristol-Myers Squibb drug and uses Viread, Emtriva and a new Gilead drug called elvitegravir plus an elvitegravir booster.
Wall Street analysts have pegged the pill as a $4 billion-a-year ...

Read more: Biotech: Pill to watch-Gilead Sciences' Quad pill | San Francisco Business Times 

AIDS Breakthrough: Astragalus Root Could Replace HIV Drugs

Thursday, November 13, 2008 by: Sherry Baker, Health Sciences Editor

(NaturalNews) Could an herbal therapy that's been used for centuries in Chinese medicine to strengthen the immune system hold the key to an effective treatment for Acquired Immune Deficiency Syndrome, better known as AIDS? A new study by scientists at the UCLA AIDS Institute says that's possible.

The research, set to be published in the Journal of Immunology November 15th, concludes astragalus root contains a substance that could make it a powerful weapon in the fight against the HIV virus that causes AIDS. "This has the potential to be either added to or possibly even replace the HAART (highly active antiretroviral therapy), which is not tolerated well by some patients and is also costly," co-author Rita Effros, a professor of pathology and laboratory medicine at the David Geffen School of Medicine at UCLA and member of the UCLA AIDS Institute, said in a press statement.